AGT and hypertensive disorder: Treatment with BRD4 inhibitor JQ-1 ameliorates AngII-induced hypertension, medial hypertrophy, and inflammation in vivo in mice [69], further underscoring the promise of such epigenetic modifiers for the treatment of human hypertension.